9 Sep 2016

Multiple sclerosis research update from MS Alliance

Dr Steven Petratos with his poster
The International Progressive MS Alliance published a recent project update, featuring the research of Dr Steven Petratos (pictured):
"Dr Petratos, who undertook the only Australian-led project from this round of funding, was investigating the role of a molecule called Nogo-A in nerve fibre damage in progressive MS. The researchers were aiming to block Nogo-A by delivering agents directly to the brain and spinal cord to hopefully limit MS-like disease in laboratory models of MS. The research team investigated the role of the Nogo-A related gene (known as NgR1) in nerve fibre degeneration and found that by blocking this gene they could limit nerve fibre damage and the subsequent neurodegeneration."

No comments:

Post a Comment

Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.intranet@monash.edu.

Related Posts Plugin for WordPress, Blogger...